Vanja Sikirica
Moderna Therapeutics (United States), Cambridge · United States
Editorial leadership for Journal of ADHD And Care ISSN 3066-8042
Biography
Vanja Sikirica is affiliated with Moderna Therapeutics in Cambridge, United States, where she applies expertise in health economics, outcomes research, and epidemiology developed through prior leadership roles at Shire Pharmaceuticals. She holds a Pharm.D. from the University of Maryland Baltimore (1999–2003), completed a fellowship in epidemiologic and statistics coursework at Jefferson Medical College of Thomas Jefferson University (2003–2005), and earned an MPH in Epidemiology, Statistics, and Health Finance and Management from The Johns Hopkins University (2007–2010). Her research focuses on real-world evidence and outcomes research, exemplified by her most-cited publication, "A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases" (2024), which has been cited 21 times. Her career reflects a sustained commitment to advancing evidence-based decision-making in pharmaceutical development and regulatory science.
Selected publications
- A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases 2024 cited 21×
- Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study 2017 cited 3×
- Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States 2023 cited 3×
- Impact of nonsegmental vitiligo on patients’ health-related quality of life in the United States 2022 cited 2×
- Disease Burden and Pharmacological Treatment Patterns in Children and Adults With Phenylketonuria: A Real‐World Matched Cohort Study Recent 2026
- Economic burden of propionic acidemia in the United States: a claims-based study Recent 2025
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JAC for your work?
This journal is guided by Vanja Sikirica (Moderna Therapeutics (United States), Cambridge) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.